Discussions on Diversity
Listening and learning from patients and physicians about critical barriers to accessing clinical research and ways to overcome them.
Watch VideoSupporting greater understanding
Through these series of reports, we will share feedback from both our quantitative and qualitative research sources to support greater understanding and highlight areas for action.
Discussion Chapters
Expert Insight
Discussion on Diversity reports provide in-depth, expert insight from a range of seasoned professionals with extensive knowledge about life sciences, patient advocacy, life sciences, and diversity, equity, and inclusion in healthcare.
The purpose of the report is to speak to people from these diverse communities, understand the barriers, understand the challenges in regard to research, and get their feedback and their input about ways to overcome them. By working with people to listen, understand, and ensure that we are giving equitable access to clinical research and making sure that our study population is reflective of the patient population. By working with these patient communities and sites, we can then build a roadmap for the particular services and tools to be successful. Through these reports, Parexel intends to support sponsors, even our competitors, and the industry at large to make sure that we're designing more inclusive clinical trials.
Our Research Methods
Patient focus groups
Hosted semi-structured roundtables with Black, Latinx, Asian, transgender and non-binary members of Parexel’s Patient Advisory Councils in Australia, Germany, Italy, UK and US.
Physician and site staff focus groups
Held in-depth discussions with medical professionals across US and Canada.
Quantitative surveys
Received input from 1,945 respondents across a broad range of racial and ethnic groups in Australia, Canada, France, Hungary, Italy, Mexico, Poland, Spain, UK and US.
Video and audio one-on-one interviews
Conducted interviews with Black, Latinx and Asian members of the UK and US public.
Research
Conducted a series of scientific literature searches for articles published from January 2018 to July 2022 that specifically mentioned transgender or non-binary patients.
The contents of this report are the opinions of third parties derived from surveys, focus group sessions, interviews and patient advisory group meetings and do not reflect the opinions or positions of Parexel or its affiliates.